Pre-exposure with low-dose UVA suppresses lesion development and enhances Th1 response in BALB/c mice infected with Leishmania (Leishmania) amazonensis
Nm. Khaskhely et al., Pre-exposure with low-dose UVA suppresses lesion development and enhances Th1 response in BALB/c mice infected with Leishmania (Leishmania) amazonensis, J DERMA SCI, 26(3), 2001, pp. 217-232
This study was conducted to determine w(h alpha)ether exposing mice to ultr
aviolet (UV) radiation would alter the pathogenesis of infection with Leish
mania (Leishmania) amazonensis (L. amazonensis) which causes progressive cu
taneous disease in susceptible mouse strains. BALB/c mice were irradiated w
ith 10 and 30 J/cm(2) UVA on shaved skin of the back from Dermaray (M-DMR-1
00) for 4 consecutive days before infection with Leishmania promastigotes.
The course of disease was recorded by measuring the size of lesions at vari
ous times after infection. Mice groups irradiated with UVA 10 and 30 J/cm(2
) showed significantly suppressed lesion development compared with the non-
irradiated mice. Light and electron microscopy revealed a few parasites at
the site of inoculation in UVA-irradiated subjects. Sandwich enzyme-linked-
immunosorbent-assay (ELISA) examination of sera showed dose dependently upr
egulated interferon-gamma (IFN-gamma), tumor necrosis factor-alpha (TNF-alp
ha) and interleukin (IL)-12, and downregulated interleukin (IL)-4 and inter
leukin (IL)-10 levels in UVA-irradiated as compared with the non-irradiated
mice. Positive signals for IFN-gamma mRNA in irradiated mice were obtained
by RT-PCR. while non-irradiated mice showed negative results. None of the
examined samples showed signal for IL-4 mRNA. The present study disclosed t
hat exposure of mice to different low-doses of UVA irradiation prior to inf
ection may interfere with immunity to L. amazonensis in the murine model. T
his indicates that the cell-mediated response switch from Th2 to Th1 patter
n suppressed the cutaneous lesions of L. amazonensis. (C) 1001 Elsevier Sci
ence Ireland Ltd. All rights reserved.